Patents Assigned to Samsung Life Public Welfare Foundation
  • Publication number: 20210378607
    Abstract: An embodiment of the present disclosure provides an adjustable couch that can be mounted on a medical couch, the adjustable couch comprising: a first couch provided with a fixing means to be fixed to the medical couch; and a second couch disposed on the first couch and provided with a rotating-coupling means to be coupled rotatably about a first axis perpendicular to an upper surface of the first couch.
    Type: Application
    Filed: September 25, 2019
    Publication date: December 9, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Moon Ki Chae, Dong Yeol Kwon, Sung Hoon Joo
  • Publication number: 20210369979
    Abstract: The present disclosure provides an apparatus for intracranial drug injection including a body unit having a through-hole extending between a first opening in a topmost surface and a second opening in a bottommost surface, a cap unit having a shape corresponding to at least a part of an inner surface of the through-hole and being inserted into the first opening to cover the first opening, and a tube unit having one end coupled to the second opening and another end extending toward an affected brain lesion.
    Type: Application
    Filed: October 31, 2018
    Publication date: December 2, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Duk Lyul Na, Jeongmin Lee, Wooram Jung, Jung-ll Lee
  • Patent number: 11185553
    Abstract: The present invention relates to a composition for preventing, treating, or alleviating ischemia-reperfusion injury, containing bile acid. According to the present invention, bile acid increases intranuclear beta-catenin levels, interferes with the opening of a mitochondria permeable transition pore (mPTP), and has excellent effects, in ischemia-reperfusion injury animal models, of alleviating tissue injury and reducing the size of infarcts, thereby being usable in the prevention, treatment, or alleviation of ischemia-reperfusion injury.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 30, 2021
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Hyeon Cheol Gwon, Hyung Suk Jang
  • Publication number: 20210348107
    Abstract: The technology described herein is directed to devices, systems, methods, and assays comprising electrode arrays for electroconductive cells. In particular, the technology generally relates to a microelectrode array (MEA) device comprising both field potential (FP) electrodes and impedance electrodes (IE) that are spatially separated for the functional analysis of the electrical connectivity between at least two cell populations, for example a plurality of neuronal cells and a plurality of contractile cells.
    Type: Application
    Filed: September 19, 2019
    Publication date: November 11, 2021
    Applicants: UNIVERSITY OF WASHINGTON, SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Deok-Ho KIM, Byung-Ok CHOI, Alexander S.T. SMITH
  • Publication number: 20210303900
    Abstract: Provided are a method and an apparatus for measuring an endolymphatic hydrops ratio of inner ear organs using an artificial neural network. The method of measuring an endolymphatic hydrops ratio includes obtaining a plurality of frame images obtained by capturing inner ear organs, obtaining a plurality of pieces of mask data corresponding to each of the plurality of frame images by inputting the plurality of frame images into a neural network, clustering the plurality of pieces of mask data according to the inner ear organs and obtaining representative images according to the inner ear organs according to certain conditions, and overlapping a target image synthesized by using the plurality of frame images and the representative images according to the inner ear organs so as to measure an endolymphatic hydrops ratio.
    Type: Application
    Filed: March 24, 2021
    Publication date: September 30, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Won-Ho Chung, Baek Hwan Cho, Young Sang Cho, Chae Jung Park
  • Patent number: 11116523
    Abstract: Provided is a femoral tunnel guide device including: a handle; a guide tube coupled to the handle and extending in one direction: and an offset unit extending from the guide tube and spaced apart by a predetermined distance from a virtual extension line of the guide tube in the one direction.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: September 14, 2021
    Assignee: Samsung Life Public Welfare Foundation
    Inventor: Chul Won Ha
  • Publication number: 20210249114
    Abstract: A method of controlling a stimulator by using image data includes receiving coordinate data of a plurality of stimulus units from a user terminal or a stimulator connected to the user terminal, obtaining, from a hospital terminal, primary image data including coordinate data of a target area estimated to be an affected area of a user, generating matching data by matching the coordinate data of the plurality of stimulus units to the primary image data, generating stimulus intensity control data capable of controlling stimulus intensities of the plurality of stimulus units by using the matching data, and transmitting the stimulus intensity control data to the user terminal.
    Type: Application
    Filed: April 22, 2019
    Publication date: August 12, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventor: Gyu Ha Ryu
  • Patent number: 11041963
    Abstract: A device for measuring a radiation dose according to the present invention includes a radiation exposure unit which exposes radiation, a frame unit which supports the radiation exposure unit, a measurement housing unit which is mounted on the frame unit, a scintillation unit which is mounted on the measurement housing unit and emits light due to the radiation exposed by the radiation exposure unit, an image capturing unit which captures an image of the scintillation unit, and a dose measuring unit which measures, on the basis of the captured image obtained by the image capturing unit, a dose of radiation to which the scintillation unit is exposed.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: June 22, 2021
    Assignees: Research & Business Foundation Sungkyunkwan University, SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Young Yih Han, Won Joong Cheon, Hyun Uk Jung, Moon Hee Lee, Sung Koo Cho
  • Patent number: 11013495
    Abstract: A method for registering medical images of different types, includes: receiving a selection of at least one point in a first medical image that is acquired in non-real time; extracting, from the first medical image, a first anatomic object which includes the selected point and a second anatomic object which is adjacent to the selected point; extracting, from a second medical image that is acquired in real time, a third anatomic object which corresponds to the first anatomic object and a fourth anatomic object which corresponds to the second anatomic object; and registering the first medical image and the second medical image based on a geometric relation between the first, second, third, and fourth anatomic objects.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: May 25, 2021
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG LIFE PUBLIC WELFARE FOUNDATION.
    Inventors: Youngkyoo Hwang, Jungbae Kim, Youngtaek Oh, Wonchul Bang, Minwoo Lee
  • Patent number: 10976389
    Abstract: An RF coil structure used for a magnetic resonance imaging (MRI) system includes a main loop coil having a first electric conductor and a second electric conductor facing the first electric conductor, and an auxiliary loop coil forming an angle ? with the main loop coil and having a third electric conductor and a fourth electric conductor facing the third electric conductor between the first electric conductor and the second electric conductor.
    Type: Grant
    Filed: January 2, 2015
    Date of Patent: April 13, 2021
    Assignees: Samsung Electronics Co., Ltd., Samsung Life Public Welfare Foundation
    Inventors: Kyoungnam Kim, Yeon Hyeon Choe
  • Publication number: 20210087620
    Abstract: A target gene identifying method for tumor treatment according to the present invention comprises the steps of: taking multiple samples from a patent's tumor; analyzing the multiple samples for genetic variation: subjecting the multiple samples to drug screening to measure drug sensitivity of each sample; analyzing tumor heterogeneity on the basis of the genetic variation analysis result and the drug sensitivity measurement result; and identifying a target gene of the tumor on the basis of the tumor heterogeneity analysis result.
    Type: Application
    Filed: February 5, 2018
    Publication date: March 25, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Do-Hyun Nam, Jin Ku Lee, Jason Kyung Ha Sa
  • Publication number: 20210063379
    Abstract: Provided is a method of screening a customized growth factor combination for cell culture, the method including: adding at least one growth factor and cells isolated from a subject to a culture medium; culturing the cells; and measuring cell proliferative activity of the cells. According to the method of screening cell-customized cell culture conditions according to one aspect, it is possible to efficiently select the optimal conditions for cell culture.
    Type: Application
    Filed: September 7, 2018
    Publication date: March 4, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Do-Hyun NAM, Hyun Ju KANG, Kayoung SHIN
  • Patent number: 10932732
    Abstract: Provided is a radiation shielding device according to various embodiments. The radiation shielding device includes: a body structure forming a receiving space receiving a user's body part, wherein a through passage penetrating an inside of the body structure is formed in the body structure; a shielding unit positioned to reciprocatively move along the through passage, wherein a shielding pad configured to shield the radiation is included in a portion of the shielding unit; and a driver configured to transfer a driving force to the shielding unit to cause the shielding unit to reciprocatively move.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: March 2, 2021
    Assignee: Samsung Life Public Welfare Foundation
    Inventors: Sang Hun Kim, Sung Ryong Kim, Pyoung Jeon, Won Hong Cho
  • Publication number: 20210057040
    Abstract: Provided are a gene panel for personalized medicine, a method of constructing the same, and a personalized treatment method using the same. In one aspect, the method of constructing the gene panel, based on an individual's genomic sequence mutation information, may detect gene mutations related to intractable diseases including cancer, and therefore, personalized treatments considering cancer progression or change in patients and treatment models of the diseases may be constructed.
    Type: Application
    Filed: January 30, 2019
    Publication date: February 25, 2021
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Yeon Jeong Kim, Donghyun Park, Woong-Yang Park
  • Patent number: 10925566
    Abstract: An X-ray imaging apparatus includes an X-ray generator configured to generate X-rays and radiate the X-rays to an object; an X-ray detector configured to detect the X-rays that have passed through the object and convert the X-rays into a signal; and a controller configured to generate a single energy X-ray image and multiple energy X-ray images including a first X-ray image generated using an X-ray having determined energy band that is extracted from the X-rays detected by the X-ray detector. The multiple energy X-ray images further include a second X-ray image in which a specific substance is separated, which is image is generated using the image signals corresponding to the energy bands from the detected X-rays, respectively, and the controller is further configured to control a display to display the single energy X-ray image and the first X-ray image and the second X-ray image on a screen of the display.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: February 23, 2021
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG LIFE PUBLIC WELFARE FOUNDATION.
    Inventors: Hyun Hwa Oh, Young Hun Sung, Kang Eui Lee, Myung Jin Chung
  • Patent number: 10898126
    Abstract: The present invention provides a triple fusion imaging device for sentinel lymphadenectomy for laparoscopic surgery including: a composite laparoscope for near infrared ray/gamma ray/visible ray acquisition configured to acquire triple images of a gamma ray from a gamma ray radioactive material injected to a diseased part, a visible ray, and a near infrared ray; an optical fiber configured to transmit the triple images acquired from the composite laparoscope; an optical source configured to generate a white light for acquiring a visible image through the optical fiber and a near infrared ray excitation light for acquiring a near infrared ray image by exciting a near infrared ray emitting fluorescence material at the disease part; an optical-to-electrical conversion module configured to separate individual images of the visible ray, near infrared ray and gamma ray from the triple images delivered through the optical fiber and then respectively convert the individual images to electrical signals; a matching uni
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: January 26, 2021
    Assignees: EULJI UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION, SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCE
    Inventors: Seong Jong Hong, Han Gyu Kang, Gun Chul Hong, Hyung Seok Lee, Kyeong Min Kim, Ho Young Lee, Seung Hoon Lee, Jong Hun Lee
  • Patent number: 10852307
    Abstract: The present invention is related to novel methods for identifying a population of subjects that are at risk for developing of atopic allergic diseases, and to the prevention of these allergic diseases.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: December 1, 2020
    Assignees: National Jewish Health, Samsung Life Public Welfare Foundation
    Inventors: Donald Y. M. Leung, Byung Eui Kim, Jihyun Kim, Kangmo Ahn
  • Publication number: 20200370102
    Abstract: Provided are biomarkers that are sensitive or resistant to poziotinib therapy for cancer and methods of using the biomarkers.
    Type: Application
    Filed: November 14, 2018
    Publication date: November 26, 2020
    Applicants: HANMI PHARM. CO., LTD., NATIONAL CANCER CENTER, SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Yeon Hee PARK, Kyung Hee PARK, Eun Jin LEE, Woong Yang PARK, Min Chae KIM, Young Whan PARK, Jung Yong KIM
  • Publication number: 20200355615
    Abstract: The present invention relates to a target gene-detecting device and a method for detecting a target gene. According to an aspect, a target gene-detecting device can be conveniently fabricated at low cost by employing a porous substrate or a method for detecting a target gene allows the pretreatment of a sample, the extraction of a nucleic acid, the amplification of a nucleic acid, and the detection of a target gene to be conducted at high accuracy and specificity in an integral system, with no contamination plausibility and can be thus useful for gene inspection.
    Type: Application
    Filed: August 28, 2018
    Publication date: November 12, 2020
    Applicant: Samsung Life Public Welfare Foundation
    Inventors: Min Young LEE, Min Hee KANG, Hyun Ju PARK, Dong Ho KIM, Sung Gyu PARK, Ho Sang JUNG
  • Patent number: 10815533
    Abstract: The present invention relates to a biomarker composition for diagnosing anticancer drug resistance of gastric cancer, including an FGFR2-ACSL5 fusion gene or a protein that the fusion gene encodes, a composition and a kit for diagnosing anticancer drug resistance of gastric cancer, including a preparation which detects an mRNA or protein of the fusion gene, and a method for diagnosing anticancer drug resistance of gastric cancer by using the biomarker. It is possible to diagnose in advance whether resistance to the drug will be exhibited during the treatment with the FGFR inhibitor by detecting an mRNA of the FGFR2-ACSL5 fusion gene according to the present invention or a protein which the gene encodes in a tissue derived from the patient with gastric cancer, so that the treatment efficiency can be enhanced by applying a more appropriate treatment to the patient.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: October 27, 2020
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Jeeyun Lee, Kyoung Mee Kim